Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
Novartis gains approval for Gilenya® as a first-line disease modifying oral therapy for multiple sclerosis in Switzerland and Australia
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) (LIBRETTO)
Cardiotoxicity of mitoxantrone treatment in a german cohort of 639 multiple sclerosis patients.
Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
Cluster-tic syndrome as the initial manifestation of multiple sclerosis.
Laquinimod
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Durable pharmacological responses from the peptide drug ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease.
Puma, but not noxa is essential for oligodendroglial cell death.
Risk factors for rare diseases can be risky to define: PML and natalizumab.
Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
Clinical profile of malay children with optic neuritis.
Effect of glatiramer acetate three-times weekly on the evolution of new, active multiple sclerosis lesions into T1-hypointense "black holes": a post hoc magnetic resonance imaging analysis.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Physiopathological Roles of p2x Receptors in the Central Nervous System.
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.

Pages